MedPath

Mechanisms of Immunmodulation in Septic Shock via Early Extracorporeal Hemadsorptio

Not Applicable
Conditions
Septic Shock
Registration Number
DRKS00028628
Lead Sponsor
niversitätsklinikum Würzburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
58
Inclusion Criteria

Septic shock with hyperinflammation, Age > 18y, written consent

Exclusion Criteria

Age > 85y, acute coronary syndrome, severe drug-induced immunosuppression, fatal co-morbidity

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction of cumulative vasopressor-dose after 72h
Secondary Outcome Measures
NameTimeMethod
Moleculare analyses of humoral and celullar immune responses, organ dysfunction, length of mechanical ventilation, length of ICU stay
© Copyright 2025. All Rights Reserved by MedPath